Back
Seres Therapeutics Quote, Financials, Valuation and Earnings
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
MCRB
Seres Therapeutics
Last Price:
0.92
Seasonality Move:
-14.51%
7 Day Trial
ALL ACCESS PASS
$
7
Do you own any of the "SELL" rated stocks on this list?
Go here now to get free instant access to all 20 stocks to sell.Seres Therapeutics Price Quote
$0.92
+0.00 (+10.58%)
(Updated: September 28, 2024 at 6:47 AM ET)
Seres Therapeutics Key Stats
Sell
35
Seres Therapeutics (MCRB)
is a Sell
Day range:
$0.84 - $1.01
52-week range:
$0.54 - $2.46
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.01
P/B ratio:
0%
Volume:
10.8M
Avg. volume:
4.4M
1-year change:
-61.55%
Market cap:
$139.4M
Revenue:
$126.3M
EPS:
$-1.18
How Much Does Seres Therapeutics Make?
Data Unavailable
Is Seres Therapeutics Growing As A Company?
Data Unavailable
Seres Therapeutics Stock Price Performance
-
Did Seres Therapeutics Stock Go Up Last Month?
Seres Therapeutics share price went up by 10.71% last month -
Did MCRB's Share Price Rise Over The Last Year?
MCRB share price fell by -61.55% over the past 1 year
What Is Seres Therapeutics 52-Week High & Low?
-
What Is Seres Therapeutics’s 52-Week High Share Price?
Seres Therapeutics has traded as high as $2.46 over the past 52 weeks -
What Is Seres Therapeutics’s 52-Week Low Share Price?
Seres Therapeutics has traded as low as $0.54 over the past 52 weeks
Seres Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Seres Therapeutics?
-
How Much Debt Does Seres Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Seres Therapeutics Have?
Cash and short term investments quarterly total is $71.2M -
What Is Seres Therapeutics’s Book Value Per Share?
Book value per share is -0.57
Is Seres Therapeutics Cash Flow Positive?
-
What Is MCRB Cash Flow From Operations?
Cash flow from operations (TTM) is -$181.8M -
What Is Seres Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $26.6M -
What Is Seres Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.4M
Seres Therapeutics Return On Invested Capital
Data Unavailable
Seres Therapeutics Earnings Date & Stock Price
-
What Is Seres Therapeutics's Stock Price Today?
A single share of MCRB can be purchased today for 0.92 -
What Is Seres Therapeutics’s Stock Symbol?
Seres Therapeutics trades on the nasdaq under the ticker symbol: MCRB -
When Is Seres Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Seres Therapeutics is scheduled on November 1, 2024 -
When Is MCRB's next ex-dividend date?
Seres Therapeutics's next ex-dividend date is September 28, 2024 -
How To Buy Seres Therapeutics Stock?
You can buy Seres Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Seres Therapeutics Competitors
-
Who Are Seres Therapeutics's Competitors?
Below is a list of companies who compete with Seres Therapeutics or are related in some way:
Seres Therapeutics Dividend Yield
-
What Is MCRB Dividend Yield?
Seres Therapeutics’s dividend yield currently is 0% -
What Is Seres Therapeutics’s Payout Ratio?
Seres Therapeutics’s payout ratio is 0% -
When Did Seres Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 28, 2024 -
What Is Seres Therapeutics’s Dividend Per Share?
Seres Therapeutics pays a dividend of $0.00 per share
Seres Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 25.52% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 3.34 |
| Upside from Last Price: | 263.21% |